Literature DB >> 25128519

Tubular urate transporter gene polymorphisms differentiate patients with gout who have normal and decreased urinary uric acid excretion.

Rosa J Torres1, Eugenio de Miguel2, Rebeca Bailén2, José R Banegas2, Juan G Puig2.   

Abstract

OBJECTIVE: Primary gout has been associated with single-nucleotide polymorphisms (SNP) in several tubular urate transporter genes. No study has assessed the association of reabsorption and secretion urate transporter gene SNP with gout in a single cohort of documented primary patients with gout carefully subclassified as normoexcretors or underexcretors.
METHODS: Three reabsorption SNP (SLC22A12/URAT1, SLC2A9/GLUT9, and SLC22A11/OAT4) and 2 secretion transporter SNP (SLC17A1/NPT1 and ABCG2/BRCP) were studied in 104 patients with primary gout and in 300 control subjects. The patients were subclassified into normoexcretors and underexcretors according to their serum and 24-h urinary uric acid levels under strict conditions of dietary control.
RESULTS: Compared with control subjects, patients with gout showed different allele distributions of the 5 SNP analyzed. However, the diagnosis of underexcretor was only positively associated with the presence of the T allele of URAT1 rs11231825, the G allele of GLUT9 rs16890979, and the A allele of ABCG2 rs2231142. The association of the A allele of ABCG2 rs2231142 in normoexcretors was 10 times higher than in underexcretors. The C allele of NPT1 rs1165196 was only significantly associated with gout in patients with normal uric acid excretion.
CONCLUSION: Gout with uric acid underexcretion is associated with transporter gene SNP related mainly to tubular reabsorption, whereas uric acid normoexcretion is associated only with tubular secretion SNP. This finding supports the concept of distinctive mechanisms to account for hyperuricemia in patients with gout with reduced or normal uric acid excretion.

Entities:  

Keywords:  ARTHRITIS; GENE POLYMORPHISM; GOUT

Mesh:

Substances:

Year:  2014        PMID: 25128519     DOI: 10.3899/jrheum.140126

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  11 in total

Review 1.  Associations between SLC2A9 polymorphisms and gout susceptibility : A meta-analysis.

Authors:  Y H Lee; Y H Seo; J-H Kim; S J Choi; J D Ji; G G Song
Journal:  Z Rheumatol       Date:  2017-02       Impact factor: 1.372

Review 2.  Crystal arthritides - gout and calcium pyrophosphate arthritis : Part 1: Epidemiology and pathophysiology.

Authors:  S Schlee; L C Bollheimer; T Bertsch; C C Sieber; P Härle
Journal:  Z Gerontol Geriatr       Date:  2017-02-23       Impact factor: 1.281

Review 3.  Association between SLC2A9 (GLUT9) gene polymorphisms and gout susceptibility: an updated meta-analysis.

Authors:  Xu Zhang; Xiao Yang; Mengmeng Wang; Xiaona Li; Qing Xia; Shengqian Xu; Jianhua Xu; Guoqi Cai; Li Wang; Lihong Xin; Yanfeng Zou; Faming Pan
Journal:  Rheumatol Int       Date:  2016-06-02       Impact factor: 2.631

Review 4.  Uric acid extrarenal excretion: the gut microbiome as an evident yet understated factor in gout development.

Authors:  Eder Orlando Méndez-Salazar; Gabriela Angélica Martínez-Nava
Journal:  Rheumatol Int       Date:  2021-09-29       Impact factor: 2.631

5.  Weak Association Between Genetic Markers of Hyperuricemia and Cardiorenal Outcomes: Insights From the STANISLAS Study Cohort With a 20-Year Follow-Up.

Authors:  Mehmet Kanbay; Constance Xhaard; Edith Le Floch; Claire Dandine-Roulland; Nicolas Girerd; João Pedro Ferreira; Jean-Marc Boivin; Sandra Wagner; Delphine Bacq-Daian; Jean-François Deleuze; Faiez Zannad; Patrick Rossignol
Journal:  J Am Heart Assoc       Date:  2022-04-26       Impact factor: 6.106

6.  Multiple Gouty Tophi with Bone Erosion and Destruction: A Report of an Early-onset Case in an Obese Patient.

Authors:  Reiko D Hayashi; Masaya Yamaoka; Hitoshi Nishizawa; Shiro Fukuda; Yuya Fujishima; Takekazu Kimura; Jyunji Kozawa; Shunbun Kita; Taka-Aki Matsuoka; Michio Otsuki; Akihisa Imagawa; Kimiyoshi Ichida; Atsuo Taniguchi; Norikazu Maeda; Tohru Funahashi; Iichiro Shimomura
Journal:  Intern Med       Date:  2017-05-01       Impact factor: 1.271

Review 7.  ABCG2 polymorphisms in gout: insights into disease susceptibility and treatment approaches.

Authors:  M C Cleophas; L A Joosten; L K Stamp; N Dalbeth; O M Woodward; Tony R Merriman
Journal:  Pharmgenomics Pers Med       Date:  2017-04-20

8.  Diagnosis and treatment for hyperuricaemia and gout: a protocol for a systematic review of clinical practice guidelines and consensus statements.

Authors:  Qianrui Li; Xiaodan Li; Joey Sum-Wing Kwong; Hao Chen; Xin Sun; Haoming Tian; Sheyu Li
Journal:  BMJ Open       Date:  2017-06-23       Impact factor: 2.692

Review 9.  Multiple Membrane Transporters and Some Immune Regulatory Genes are Major Genetic Factors to Gout.

Authors:  Weifeng Zhu; Yan Deng; Xiaodong Zhou
Journal:  Open Rheumatol J       Date:  2018-07-24

Review 10.  Physiology of Hyperuricemia and Urate-Lowering Treatments.

Authors:  Caroline L Benn; Pinky Dua; Rachel Gurrell; Peter Loudon; Andrew Pike; R Ian Storer; Ciara Vangjeli
Journal:  Front Med (Lausanne)       Date:  2018-05-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.